Management Practices for Methicillin-Resistant Staphylococcus aureus Bacteremia by Adult Infectious Diseases Physicians

To assess current use of vancomycin for methicillin-resistant Staphylococcus aureus bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Banniettis, Natalie, Beekmann, Susan E, Polgreen, Philip M, Kaushik, Shubhi, Kohlhoff, Stephan, Gilbert, David, Bennett, John E, Hammerschlag, Margaret R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5961149/
https://www.ncbi.nlm.nih.gov/pubmed/29876367
http://dx.doi.org/10.1093/ofid/ofy093
Descripción
Sumario:To assess current use of vancomycin for methicillin-resistant Staphylococcus aureus bacteremia, we surveyed adult infectious disease physicians. Most respondents reported personal experience with infections failing to respond to vancomycin despite minimum inhibitory concentration data indicating susceptibility. In a hypothetical case of such an infection, most would change to daptomycin with or without other agents.

Ejemplares similares